BusinessApricus Biosciences Announces the Launch of Vitaros® for the Treatment of Erectile Dysfunction in Lebanon by Elis PharmaceuticalsBy Nasdaq OMXDec 27, 2016, 12:00 PM UTC
BusinessMacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADCBy Nasdaq OMXDec 12, 2016, 9:30 PM UTC
BusinessPerry Ellis International Announces Boy's Tailored Clothing License for Perry Ellis BrandBy Nasdaq OMXNov 8, 2016, 2:30 PM UTC
BusinessApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in GreeceBy Nasdaq OMXOct 26, 2016, 11:00 AM UTC
BusinessMyriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with DiabetesBy Nasdaq OMXOct 25, 2016, 11:05 AM UTC
BusinessApricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by RecordatiBy Nasdaq OMXSep 21, 2016, 11:00 AM UTC
BusinessApricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for Vitaros® in Finland and Denmark to Ferring PharmaceuticalsBy Nasdaq OMXSep 20, 2016, 11:01 AM UTC
BusinessApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in ArgentinaBy Nasdaq OMXSep 8, 2016, 11:00 AM UTC
